Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

CA19-9

  • Open Access
    Stage IV Pancreatic Cancer Patient Treated With FOLFIRINOX Combined With Oral Methioninase: A Highly-Rare Case With Long-term Stable Disease
    YUTARO KUBOTA, QINGHONG HAN, CHIHIRO HOZUMI, NORIYUKI MASAKI, JUN YAMAMOTO, YUSUKE AOKI, TAKUYA TSUNODA and ROBERT M. HOFFMAN
    Anticancer Research May 2022, 42 (5) 2567-2572; DOI: https://doi.org/10.21873/anticanres.15734
  • You have access
    The Clinical Significance of CA19-9 and Tumor Size Ratios for Predicting Prognosis After Conversion Surgery in Patients With Stage IV Gastric Cancer
    KEISHI OKUBO, TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, YOSHIKAZU UENOSONO, SHIGEHIRO YANAGITA, TAKASHI KIJIMA, YUSUKE TSURUDA, MASAHIRO NODA, KEN SASAKI, SHINICHIRO MORI, HIROSHI KURAHARA and TAKAO OHTSUKA
    Anticancer Research November 2021, 41 (11) 5643-5649; DOI: https://doi.org/10.21873/anticanres.15380
  • You have access
    Clinical Predictors of Unresectable Disease at Laparotomy in Patients With Pancreatic Ductal Adenocarcinoma Planning to Undergo Surgical Resection
    TAKAYUKI SHIMIZU, TAKU AOKI, SHUN SATO, TAKATSUGU MATSUMOTO, TAKAYUKI SHIRAKI, YUHKI SAKURAOKA, SHOZO MORI, YUKIHIRO ISO, MITSURU ISHIZUKA and KEIICHI KUBOTA
    Anticancer Research October 2021, 41 (10) 5171-5177; DOI: https://doi.org/10.21873/anticanres.15335
  • You have access
    Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker?
    CHUN-YI TSAI, KENG-HAO LIU, CHENG-TANG CHIU, SHUN-WEN HSUEH, CHIA-YEN HUNG, JUN-TE HSU, NGAN-MING TSANG, YU-SHIN HUNG and WEN-CHI CHOU
    Anticancer Research May 2021, 41 (5) 2711-2718; DOI: https://doi.org/10.21873/anticanres.15052
  • You have access
    Carbohydrate Antigen 19-9 Is a Prognostic Factor Which Correlates With HDAC1 and HIF-1α for Intrahepatic Cholangiocarcinoma
    SHOGO OHTA, YUJI MORINE, SATORU IMURA, TETSUYA IKEMOTO, YUSUKE ARAKAWA, SHUICHI IWAHASHI, YU SAITO, SHINICHIRO YAMADA, YUMA WADA, SHOKO YAMASHITA, YOSHIMI BANDO and MITSUO SHIMADA
    Anticancer Research November 2019, 39 (11) 6025-6033; DOI: https://doi.org/10.21873/anticanres.13808
  • You have access
    The Value of CA19-9 After Irreversible Electroporation for Pancreatic Cancer
    CHRISTOPHER MÅNSSON, ANDERS NILSSON, JOZEF URDZIK and BRITT-MARIE KARLSON
    Anticancer Research November 2019, 39 (11) 6193-6196; DOI: https://doi.org/10.21873/anticanres.13827
  • You have access
    High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma
    HIROSHI YAEGASHI, KOUJI IZUMI, SUGURU KADOMOTO, RENATO NAITO, TOMOYUKI MAKINO, HIROAKI IWAMOTO, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI
    Anticancer Research January 2019, 39 (1) 375-380; DOI: https://doi.org/10.21873/anticanres.13122
  • You have access
    Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas
    DEMETRIOS MORIS, CHRISTOS DAMASKOS, ELEFTHERIOS SPARTALIS, ALEXANDROS PAPALAMPROS, SPYRIDON VERNADAKIS, DIMITRIOS DIMITROULIS, JOHN GRINIATSOS, EVANGELOS FELEKOURAS and NIKOLAOS NIKITEAS
    Anticancer Research May 2017, 37 (5) 2185-2194;
  • You have access
    Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI™-based Assays
    RAMONA C. DOLSCHEID-POMMERICH, STEFFEN MANEKELLER, GISELA WALGENBACH-BRÜNAGEL, JÖRG C. KALFF, GUNTHER HARTMANN, BIRGIT STOFFEL WAGNER and STEFAN HOLDENRIEDER
    Anticancer Research January 2017, 37 (1) 353-359;
  • You have access
    Better Outcomes by Monitoring Tumour Dynamics Using Sensitive Tumour Markers in Patients with Recurrent Gastric Cancer
    SHUHEI KOMATSU, DAISUKE ICHIKAWA, YUKIHISA NISHIMURA, TAKESHI KUBOTA, KAZUMA OKAMOTO, ATSUSHI SHIOZAKI, HITOSHI FUJIWARA, HIROTAKA KONISHI, YASUTOSHI MURAYAMA, YOSHIAKI KURIU, HISASHI IKOMA, MASAYOSHI NAKANISHI and EIGO OTSUJI
    Anticancer Research April 2013, 33 (4) 1621-1627;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire